|
OMIM |
Link |
Information gain |
01 |
|
IGES
|
[NCBI]
|
0.0133565
|
|
|
ATOD6
|
[NCBI]
|
0.00474809
|
|
|
hyperimmunoglobulin e-recurrent infection syndrome, autosomal recessive
|
[NCBI]
|
0.00418311
|
|
|
asthma-related traits, susceptibility to, 3
|
[NCBI]
|
0.00346369
|
|
|
dermatitis, atopic
|
[NCBI]
|
0.00291705
|
|
|
IGER
|
[NCBI]
|
0.00242446
|
|
|
RNASE3
|
[NCBI]
|
0.00241835
|
|
|
hyperimmunoglobulin e recurrent infection syndrome, autosomal dominant
|
[NCBI]
|
0.00204246
|
|
|
asthma, susceptibility to
|
[NCBI]
|
0.00181586
|
|
|
ATOD5
|
[NCBI]
|
0.00155721
|
|
|
asthma-related traits, susceptibility to, 6
|
[NCBI]
|
0.00155721
|
|
|
eosinophilia, familial
|
[NCBI]
|
0.00136118
|
|
|
CF
|
[NCBI]
|
0.000757961
|
|
|
IGAD1
|
[NCBI]
|
0.000591226
|
|
|
immunodeficiency with defective leukocyte and lymphocyte function and with response to histamine-1 antagonist
|
[NCBI]
|
0.000389139
|
|
|
asthma-related traits, susceptibility to, 1
|
[NCBI]
|
0.000337958
|
|
|
ragweed sensitivity
|
[NCBI]
|
0.000294595
|
|
|
IL4
|
[NCBI]
|
0.000283763
|
|
|
STAT6
|
[NCBI]
|
0.000275323
|
|
|
asthma-related traits, susceptibility to, 2
|
[NCBI]
|
0.000215882
|
|
|
allergic rhinitis
|
[NCBI]
|
0.000215882
|
|
|
IGHE
|
[NCBI]
|
0.00019759
|
|
|
IL4R
|
[NCBI]
|
0.000187996
|
|
|
BCGF
|
[NCBI]
|
0.000184068
|
|
|
CCL17
|
[NCBI]
|
0.000177306
|
|
|
IL13
|
[NCBI]
|
0.000141136
|
|
|
FCER1A
|
[NCBI]
|
0.000135143
|
|
|
NETH
|
[NCBI]
|
0.000132979
|
|
|
vibratory angioedema
|
[NCBI]
|
0.000129607
|
|
|
splenomegaly syndrome with splenic germinal center hypoplasia and reduced circulating t-helper cells
|
[NCBI]
|
0.000129607
|
|
|
MS4A2
|
[NCBI]
|
0.000128633
|
|
|
AT
|
[NCBI]
|
0.000122954
|
|
|
immunodeficiency-centromeric instability-facial anomalies syndrome
|
[NCBI]
|
0.000100486
|
|
|
dermographism, familial
|
[NCBI]
|
9.80929e-05
|
|
|
ATOD4
|
[NCBI]
|
9.80929e-05
|
|
|
SCIDX1
|
[NCBI]
|
9.55488e-05
|
|
|
FCAS
|
[NCBI]
|
9.11386e-05
|
|
|
CCL22
|
[NCBI]
|
8.62874e-05
|
|
|
asthma-related traits, susceptibility to, 5
|
[NCBI]
|
8.62462e-05
|
|
|
FCER2
|
[NCBI]
|
7.49956e-05
|
|
|
AICDA
|
[NCBI]
|
7.48905e-05
|
|
|
immunodeficiency with hyper-igm, type 2
|
[NCBI]
|
7.28993e-05
|
|
|
epidermolysis bullosa pruriginosa
|
[NCBI]
|
7.28993e-05
|
|
|
IL21R
|
[NCBI]
|
7.26688e-05
|
|
|
immunodeficiency with hyper-igm, type 3
|
[NCBI]
|
6.83879e-05
|
|
|
EGF
|
[NCBI]
|
6.4687e-05
|
|
|
TPT1
|
[NCBI]
|
6.30719e-05
|
|
|
PHF11
|
[NCBI]
|
5.40203e-05
|
|
|
SOD2
|
[NCBI]
|
5.15033e-05
|
|
|
GPR154
|
[NCBI]
|
4.48117e-05
|
|
|
SCGB3A2
|
[NCBI]
|
4.33816e-05
|
|
|
RNASE2
|
[NCBI]
|
4.25537e-05
|
|
|
CCL11
|
[NCBI]
|
4.21229e-05
|
|
|
CVS
|
[NCBI]
|
4.05972e-05
|
|
|
VEGF
|
[NCBI]
|
3.93169e-05
|
|
|
CCL27
|
[NCBI]
|
3.82076e-05
|
|
|
JAK3
|
[NCBI]
|
3.68901e-05
|
|
|
IL9
|
[NCBI]
|
3.53647e-05
|
|
|
IL3
|
[NCBI]
|
3.50628e-05
|
|
|
PLA2G7
|
[NCBI]
|
3.47605e-05
|
|
|
CD40
|
[NCBI]
|
3.47605e-05
|
|
|
CBARA1
|
[NCBI]
|
3.44189e-05
|
|
|
LELP1
|
[NCBI]
|
3.44189e-05
|
|
|
SETDB2
|
[NCBI]
|
3.44189e-05
|
|
|
asthma-associated alternatively spliced gene 1
|
[NCBI]
|
3.44189e-05
|
|
|
nascent polypeptide-associated complex, alpha polypeptide, 2
|
[NCBI]
|
3.44189e-05
|
|
|
CVID
|
[NCBI]
|
3.43398e-05
|
|
|
PTH
|
[NCBI]
|
3.41342e-05
|
|
|
CHS
|
[NCBI]
|
3.10501e-05
|
|
|
HLA-DRB1
|
[NCBI]
|
3.08884e-05
|
|
|
MPO
|
[NCBI]
|
3.08753e-05
|
|
|
human immunodeficiency virus type 1, susceptibility to
|
[NCBI]
|
3.05934e-05
|
|
|
TNF
|
[NCBI]
|
2.83608e-05
|
|
|
PRL
|
[NCBI]
|
2.83032e-05
|
|
|
IL18
|
[NCBI]
|
2.77814e-05
|
|
|
HIGM1
|
[NCBI]
|
2.76219e-05
|
|
|
LTA
|
[NCBI]
|
2.72034e-05
|
|
|
dendritic cell nuclear protein 1
|
[NCBI]
|
2.7004e-05
|
|
|
HNMT
|
[NCBI]
|
2.49488e-05
|
|
|
CSF2
|
[NCBI]
|
2.47271e-05
|
|
|
CD300A
|
[NCBI]
|
2.42107e-05
|
|
|
NACA
|
[NCBI]
|
2.42107e-05
|
|
|
HDC
|
[NCBI]
|
2.39135e-05
|
|
|
EGFR
|
[NCBI]
|
2.39044e-05
|
|
|
IGHG1
|
[NCBI]
|
2.3492e-05
|
|
|
SH2D1A
|
[NCBI]
|
2.33004e-05
|
|
|
PF4
|
[NCBI]
|
2.31426e-05
|
|
|
ACHE
|
[NCBI]
|
2.28537e-05
|
|
|
TNFRSF21
|
[NCBI]
|
2.23998e-05
|
|
|
IGHA1
|
[NCBI]
|
2.23998e-05
|
|
|
TRPM4
|
[NCBI]
|
2.23998e-05
|
|
|
TCF7
|
[NCBI]
|
2.10554e-05
|
|
|
CCL24
|
[NCBI]
|
2.10554e-05
|
|
|
SART1
|
[NCBI]
|
2.10554e-05
|
|
|
GPR44
|
[NCBI]
|
2.10554e-05
|
|
|
thrombocytopenic purpura, autoimmune
|
[NCBI]
|
2.01608e-05
|
|
|
CMA1
|
[NCBI]
|
1.99858e-05
|
|
|
PTGDR
|
[NCBI]
|
1.99858e-05
|
|
|
NOD1
|
[NCBI]
|
1.99858e-05
|
|
|
FCER1G
|
[NCBI]
|
1.90978e-05
|
|
|
IL21
|
[NCBI]
|
1.90978e-05
|
|
|
NDST2
|
[NCBI]
|
1.90978e-05
|
|
|
CCL7
|
[NCBI]
|
1.90978e-05
|
|
|
LYN
|
[NCBI]
|
1.90978e-05
|
|
|
FOXJ1
|
[NCBI]
|
1.90978e-05
|
|
|
TACR2
|
[NCBI]
|
1.90978e-05
|
|
|
TNFRSF4
|
[NCBI]
|
1.83388e-05
|
|
|
LAT
|
[NCBI]
|
1.78148e-05
|
|
|
IL9R
|
[NCBI]
|
1.76764e-05
|
|
|
FCAR
|
[NCBI]
|
1.76764e-05
|
|
|
CCR6
|
[NCBI]
|
1.70888e-05
|
|
|
PTGS2
|
[NCBI]
|
1.64338e-05
|
|
|
TNFSF4
|
[NCBI]
|
1.60822e-05
|
|
|
SYK
|
[NCBI]
|
1.60822e-05
|
|
|
DAP3
|
[NCBI]
|
1.60822e-05
|
|
|
CCR3
|
[NCBI]
|
1.56441e-05
|
|
|
C5R1
|
[NCBI]
|
1.56441e-05
|
|
|
CCL3
|
[NCBI]
|
1.52404e-05
|
|
|
ZAP70
|
[NCBI]
|
1.52404e-05
|
|
|
LTA4H
|
[NCBI]
|
1.52404e-05
|
|
|
ICOSLG
|
[NCBI]
|
1.52404e-05
|
|
|
BPI
|
[NCBI]
|
1.52404e-05
|
|
|
TLR9
|
[NCBI]
|
1.46959e-05
|
|
|
C4BPA
|
[NCBI]
|
1.45177e-05
|
|
|
TBX21
|
[NCBI]
|
1.41914e-05
|
|
|
CERK
|
[NCBI]
|
1.41914e-05
|
|
|
C5
|
[NCBI]
|
1.41914e-05
|
|
|
TLR4
|
[NCBI]
|
1.39065e-05
|
|
|
FCGR3A
|
[NCBI]
|
1.38849e-05
|
|
|
SPHK1
|
[NCBI]
|
1.35959e-05
|
|
|
ID2
|
[NCBI]
|
1.33226e-05
|
|
|
F2RL1
|
[NCBI]
|
1.30634e-05
|
|
|
PTGS1
|
[NCBI]
|
1.28169e-05
|
|
|
WIPF1
|
[NCBI]
|
1.28169e-05
|
|
|
MIF
|
[NCBI]
|
1.28169e-05
|
|
|
MAP4K1
|
[NCBI]
|
1.23579e-05
|
|
|
LTC4S
|
[NCBI]
|
1.17404e-05
|
|
|
WAS
|
[NCBI]
|
1.1734e-05
|
|
|
INPP5D
|
[NCBI]
|
1.1368e-05
|
|
|
TCRB
|
[NCBI]
|
1.1192e-05
|
|
|
HLA-DQA1
|
[NCBI]
|
1.10221e-05
|
|
|
WBS
|
[NCBI]
|
1.09265e-05
|
|
|
LYZ
|
[NCBI]
|
1.0858e-05
|
|
|
AFP
|
[NCBI]
|
1.08191e-05
|
|
|
STAT4
|
[NCBI]
|
1.06993e-05
|
|
|
CD40LG
|
[NCBI]
|
1.06993e-05
|
|
|
IGKC
|
[NCBI]
|
1.05456e-05
|
|
|
RA
|
[NCBI]
|
1.00973e-05
|
|
|
PCNA
|
[NCBI]
|
1.005e-05
|
|
|
JAK1
|
[NCBI]
|
9.9762e-06
|
|
|
SLAMF1
|
[NCBI]
|
9.9762e-06
|
|
|
IL5
|
[NCBI]
|
9.71525e-06
|
|
|
ADRB2
|
[NCBI]
|
9.71525e-06
|
|
|
HGF
|
[NCBI]
|
9.65016e-06
|
|
|
ALPS
|
[NCBI]
|
9.63465e-06
|
|
|
fabry disease
|
[NCBI]
|
9.18957e-06
|
|
|
COL7A1
|
[NCBI]
|
8.59328e-06
|
|
|
KIT
|
[NCBI]
|
7.86026e-06
|
|
|
VIP
|
[NCBI]
|
7.64652e-06
|
|
|
C3
|
[NCBI]
|
7.61388e-06
|
|
|
APCS
|
[NCBI]
|
7.45702e-06
|
|
|
MMP9
|
[NCBI]
|
7.45702e-06
|
|
|
FOXP3
|
[NCBI]
|
6.94912e-06
|
|
|
CCL2
|
[NCBI]
|
6.25752e-06
|
|
|
IL10
|
[NCBI]
|
6.20006e-06
|
|
|
SLE
|
[NCBI]
|
6.15062e-06
|
|
|
BTK
|
[NCBI]
|
6.14341e-06
|
|
|
APC
|
[NCBI]
|
5.81421e-06
|
|
|
MBL2
|
[NCBI]
|
5.79727e-06
|
|
|
CD
|
[NCBI]
|
5.66752e-06
|
|
|
PIGR
|
[NCBI]
|
4.55265e-06
|
|
|
UCN
|
[NCBI]
|
3.76514e-06
|
|
|
STAT5A
|
[NCBI]
|
3.43314e-06
|
|
|
NGFB
|
[NCBI]
|
3.39968e-06
|
|
|
lymphoma, non-hodgkin, familial
|
[NCBI]
|
3.34541e-06
|
|
|
SLPI
|
[NCBI]
|
3.33001e-06
|
|
|
KITLG
|
[NCBI]
|
2.8416e-06
|
|
|
IL6
|
[NCBI]
|
2.69623e-06
|
|
|
BDNF
|
[NCBI]
|
2.62869e-06
|
|
|
DHFR
|
[NCBI]
|
2.62786e-06
|
|
|
SPP1
|
[NCBI]
|
2.46003e-06
|
|
|
IL2
|
[NCBI]
|
2.02669e-06
|
|
|
CRH
|
[NCBI]
|
1.89517e-06
|
|
|
CEACAM5
|
[NCBI]
|
1.8266e-06
|
|
|
PTK2
|
[NCBI]
|
1.82483e-06
|
|
|
CFTR
|
[NCBI]
|
1.44149e-06
|
|
|
panencephalitis, subacute sclerosing
|
[NCBI]
|
1.19128e-06
|
|
|
ADM
|
[NCBI]
|
8.97698e-07
|
|
|
ADA
|
[NCBI]
|
8.2536e-07
|
|
|
POMC
|
[NCBI]
|
5.77626e-07
|
|
|
STAT3
|
[NCBI]
|
5.49104e-07
|
|
|
GAPDH
|
[NCBI]
|
4.46503e-07
|
|
|
XDH
|
[NCBI]
|
3.36485e-07
|
|
|
CNTF
|
[NCBI]
|
2.61166e-07
|
|
|
TPO
|
[NCBI]
|
2.03814e-07
|
|
|
ABCC1
|
[NCBI]
|
1.95196e-07
|
|
|
PPARA
|
[NCBI]
|
1.66674e-07
|
|
|
TNFSF6
|
[NCBI]
|
1.27774e-07
|
|
|
VDR
|
[NCBI]
|
1.27774e-07
|
|
|
CTGF
|
[NCBI]
|
1.56237e-08
|
|
|
ALB
|
[NCBI]
|
5.38761e-09
|
|